I liked the line further down the page
"With the recent increased interest in biotech stocks led by stunning gains by Mesoblast and Prima Biomed, Phosphagenics are every chance to be the next biotech to be re-rated".
marketing is the key to poh growth, page-50
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.339M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $1.421K | 494.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 92875532 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20046164 | 12 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |